Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 25 (RPL31P25) is a processed pseudogene of the ribosomal protein L31 gene. Unlike the parental RPL31 gene, which encodes a structural component of the 60S ribosomal subunit involved in protein synthesis, RPL31P25 does not produce a functional protein and its direct biological role remains uncharacterized. Pseudogenes like RPL31P25 are non-coding DNA segments, usually derived from retrotransposition or duplication of functional genes, and may occasionally be transcribed but do not contribute to canonical ribosome function. There are numerous ribosomal protein pseudogenes within the human genome, and while some are implicated in gene regulation or disease in specific contexts, there is no evidence that RPL31P25 acts as a therapeutic target or has established disease relevance[6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 25 (RPL31P25).